Literature DB >> 10849380

Bruising following blood donation, its management and the response and subsequent return rates of affected donors.

E Ranasinghe1, J F Harrison.   

Abstract

A study was undertaken to determine the incidence of bruising among blood donors and to analyse their response to the management of this complication. A total of 52 510 donors were bled at 476 consecutive donor sessions held by the Brentwood Centre during a 4-month period. Of these, 344 donors (0.66%) were found to have developed bruises following venepuncture. The incidence of bruising among males was 0. 35% and that among females was 0.98%. All bruised donors were managed by the Centre nursing and medical staff. One hundred and sixty-one donors informed the Centre that they were fully satisfied with the way their bruising was managed. Of 329 bruised donors who remained in the panel, 249 (75.7%) attended subsequent blood donor sessions in response to routine invitations, showing that the majority of bruised donors continued to donate blood. This response was compared with that of a control group of donors who did not develop any complications and there was no significant difference in the return rates between the two groups.

Entities:  

Mesh:

Year:  2000        PMID: 10849380     DOI: 10.1046/j.1365-3148.2000.00240.x

Source DB:  PubMed          Journal:  Transfus Med        ISSN: 0958-7578            Impact factor:   2.019


  3 in total

1.  Adverse reactions in blood and apheresis donors: experience from two Italian transfusion centres.

Authors:  Isabella Crocco; Massimo Franchini; Giovanni Garozzo; Anna Rosa Gandini; Giorgio Gandini; Pietro Bonomo; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2009-01       Impact factor: 3.443

2.  Donor Hemovigilance with Blood Donation.

Authors:  Ulrich Diekamp; Johannes Gneißl; Angela Rabe; Stephan T Kießig
Journal:  Transfus Med Hemother       Date:  2015-01-29       Impact factor: 3.747

3.  Donor Hemovigilance during Preparatory Plasmapheresis.

Authors:  Ulrich Diekamp; Johannes Gneißl; Angela Rabe; Stephan T Kießig
Journal:  Transfus Med Hemother       Date:  2014-02-17       Impact factor: 3.747

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.